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Abstract
Background: It is well established that weight is an important determinant of bone health. Whereas obesity is
associated with increased mortality and morbidity from diabetes and cardiovascular diseases, high body weight is
widely believed to be associated to hypovitaminosis D and protective against the development of osteoporosis and
fracture risk. The objective of the study was to evaluate the effect of BMI on vitamin D status and on densitometric
vertebral fractures (VFs) in a large series of asymptomatic women aged over 50 who had a VFA examination during
their bone mineral density (BMD) testing.
Methods: We enrolled 429 postmenopausal women (mean age, weight and BMI of 59.5 ± 8.3 (50 to 83) years,
75.8 ± 13.3 (35 to 165) kgs and 29.9 ± 5.2 (14.6 to 50.8) kg/m2, respectively. Lateral VFA images and scans of the
lumbar spine and proximal femur were obtained using a Lunar Prodigy densitometer. VFs were defined using the
Genant semiquantitative (SQ) approach. Clinical risk factors of osteoporosis were collected and 25-hydroxivitamin D
was measured using electrochimiluminescence (Roche).
Results: Prevalence of osteoporosis and hypovitaminosis D (<20 ng/ml) was 21.0 % and 78.1 % respectively. VFs grade
2/3were identified in 76 (17.7 %). Comparison between women according to their BMI showed that obese women had
a higher BMD and less proportion of women with osteoporosis and VFs grade 2/3 than lean and overweight women.
The prevalence of VFs globally increased with age and as BMI and BMD declined. Stepwise regression analysis showed
that the presence of osteoporosis was independently related to BMI and history of fractures while the presence of
grade 2/3 VFs was independently related to age, hypovitaminosis D and years of menopause.
Conclusion: Obese women had a higher BMD and lower prevalence of VFs. VFs were significantly related to age,
hypovitaminosis D and years since menopause. However, among obese women, prevalence of VFs was increased in
osteoporotic women.
Keywords: Vertebral fracture assessment (VFA), Dual-energy X-ray absorptiometry (DXA), Osteoporosis, Women,
Vertebral fractures, Vitamin D
Background
Patients with osteoporosis are at increased risk for frac-
tures especially vertebral, wrist, and hip fractures [1].
Vertebral fractures (VFs) can easily go undiagnosed as
they are clinically silent in two third of the cases. More-
over, even when they are asymptomatic, they are associ-
ated with reduced quality of life, increased morbidity
and mortality, and increased risk of future vertebral and
non-VFs [2, 3]. Several studies showed that weight is an
important determinant of bone health. In early adult-
hood, weight may determine peak bone mass, and per-
sons who are overweight in young age may be at an
advantage regarding bone mass in older age. Thus,
whereas obesity is associated with increased mortality
and morbidity from diabetes and cardiovascular diseases,
high body weight is widely believed to be protective
against the development of osteoporosis and fracture
risk. The fracture assessment tool FRAX, which includes
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BMI was developed based on a meta-analysis of 12
cohorts, which showed a negative correlation between
BMI and incident hip, osteoporotic, and all fractures,
when the models did not include BMD. This finding has
been recently confirmed by the Million Women Study
[4], a large-scale observational study which found that
women with higher BMI have not only increased BMD
but also robust femur geometry assessed by hip struc-
ture analysis. The negative BMI–fracture association was
specific to hip and central body fractures [5]. However,
the effect of BMI on fracture at a given level of BMD
remains controversial, partly because of its differential
effects on different fracture sites. It has been sug-
gested that increased BMI was a protective factor of
hip fracture while obesity was a risk factor of ankle
and upper leg fractures. Confirmation that obesity
was not a protective factor against low trauma frac-
tures was reported in 2011, when the Global Study of
Osteoporosis in Women (GLOW), a multicentre pro-
spective observational study conducted in 60,393
postmenopausal women, showed a comparable preva-
lence and incidence of fractures in normal weight and
obese women [6].
The prevalence and clinical risk factors associated with
VFs have been well studied in women [7–10]. A negative
effect of BMI on VFs was found in a pan-European
study in which the prevalence of vertebral deformity in a
given country was inversely related to the mean BMI in
the study population in that country (r = −0.66) [11].
However, Pirro et al. showed that an association between
BMI and a higher likelihood of having a VF, irrespective
of the positive association between BMI and BMD [12].
We showed in a previous study that VFs prevalence was
associated to vitamin D deficiency in a cohort of post
menopausal women [13]. On the other hand, vitamin D
deficiency has been associated with obesity irrespective
of age, latitude, cut-offs to define vitamin D deficiency
and the Human Development Index of the study loca-
tion [14–17]. Thus, we aimed in the present study to
evaluate the effect of BMI on vitamin D status and on
densitometric vertebral VFs in a large series of asymp-
tomatic women aged over 50 who had a VFA examin-
ation during their bone mineral density (BMD) testing.
Methods
Subjects
This was a cross-sectional study conducted from June
2012 to June 2014 that enrolled menopausal women
50 years old and over, living in the region of Rabat. Par-
ticipants were recruited from a variety of sources includ-
ing advertisements, “word of mouth”, clinician referrals,
or from local hospital staff families. General exclusion
criteria were previous diagnosis of osteoporosis, non-
Caucasian origin and diseases, drugs, and other major
determinants known to affect bone metabolism. Thus,
we excluded subjects with gastrectomy, intestinal resec-
tion, recent hyperthyroidism or hyperparathyroidism,
recent severe immobilization or treatment with cortico-
steroids (more than 3 months). Our institutional review
board approved this study. The procedures of the study
were in accordance with the Declaration of Helsinki,
and formal ethics committee approval was obtained
for the study. Data from four hundred and twenty nine
were collected. All the participants gave an informed
and written consent. Each subject completed a stan-
dardized questionnaire designed to document putative
risk factors of osteoporosis. History of fractures, life-
style (alcohol consumption, gymnastics or jogging/
walking, smoking) and diet (milk, yogurt, cSSheese)
habits were also recorded. The women were asked
whether they usually drank milk, coffee, or alcohol, if
they ate cheese or yogurt, if they did gymnastics or
jogging/walking, and if they smoked tobacco. Dairy
products intake was then arbitrarily classified as low
(mean calcium intake <600 mg/day), normal (mean
calcium intake > 600 mg/day and ≤ 1000 mg/day), and
high (≥1000 mg/day). Physical activity was classified as
low if the women walked < 3 h/week, normal (walking
time ≥ 3 h/week and <6 h/week), and high (≥ 6 h/week).
Menstrual and reproductive history were assessed: all pa-
tients were menopausal since at least one year. Height and
weight were measured in our centre before DXA measure-
ment, in light indoor clothes without shoes. Body mass
index (BMI)] was calculated by dividing weight in kilo-
grams by height in meters squared.
BMD measurement
Bone mineral density was determined by a Lunar Prodigy
Vision DXA system (GE-Lunar Corp., Madison, WI). The
DXA scans were obtained by standard procedures sup-
plied by the manufacturer for scanning and analysis. All
BMD measurements were carried out by 2 experienced
technicians. Daily quality control was carried out by meas-
urement of a Lunar phantom. At the time of the study,
phantom measurements showed stable results. The phan-
tom precision expressed as the coefficient of variation per-
centage was 0.08. Moreover, reproducibility has been
assessed in clinical practice and showed a smallest detect-
able difference of 0.040 g/cm2 (spine) and 0.021 (total
hips) [18, 19]. Patient BMD was measured at the lumbar
spine (anteroposterior projection at L1-L4) and at the hip
(i.e., femoral neck, trochanter, and total hip). Using the
Moroccan female normative data [20], the World Health
Organization (WHO) classification system was applied,
defining osteoporosis as T-score ≤ −2.5 and osteopenia
as −2.5 < T-score < −1. Study participants were catego-
rized by the lowest T-score of the L1–4 lumbar spine,
femur neck, or total femur.
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Vertebral Fracture Assessment (VFA)
VFA was classified using a combination of Genant semi-
quantitative (SQ) approach and morphometry in the fol-
lowing manner: each VFA image was inspected visually
by one clinician (AM) who is an experienced reader of
VFA which was blinded to clinical data, to decide
whether it contained a fracture in any of the visualized
vertebrae and assigned a grade based on Genant SQ
scale [21], where grade 1 (mild) fracture is a reduction
in vertebral height of 20-25 %, grade 2 (moderate) a re-
duction of 26-40 %, and grade 3 (severe) a reduction of
over 40 %. In case of doubt regarding fracture grade, the
vertebrae in question was measured using built-in
morphometry. Automatic vertebral recognition by the
software was used. Positioning of the six morphometry
points was modified only when the software failed to
correctly recognize vertebral heights. Subjects with no
fractures were included in the non-fracture group,
whereas those with grade1 or higher fractures were in-
cluded in the fracture group. However, as many studies
rarely report mild deformities as “fractures”, and to
realize comparisons with the literature, we performed a
double analysis including and excluding grade 1 frac-
tures from the fracture group.
Laboratory evaluation
All blood samples were collected under fasting condi-
tions on the same day of acquisition of the VFA im-
ages, between 8 and 10 a.m., stored at −20 °C, and
analyzed at the same time. The serum concentration
of 25-hydroxivitamin D (25 (OH) D) was measured using
electrochimiluminescence on ELECSYS 2010 analyser
(Roche Diagnostics, Mannheim). The intra and inter-assay
variation coefficients in our laboratory were 10.5 % and
17.8 %, respectively. In the present study, 25 (OH) D
values of ≤ 20 ng/ml were defined as vitamin D insuffi-
ciency and of ≤ 10 ng/ml as vitamin D deficiency.
Statistical analysis
Results are presented as means (SD) and categorical vari-
ables are expressed as frequencies. To compare women
according to their BMI, women with normal weight, over-
weight and obesity, chi-square test and analysis of vari-
ance ANOVA were used firstly. Women with grade 1
vertebral deformities, women with grade 2/3 VFs and
women without VFs were also compared using chi-square
test and analysis of variance ANOVA. We performed
pairwise comparisons among the 3 groups using the
Bonferoni test. Significant risk factors in the univariate ana-
lysis for osteoporosis and VFs were entered to a stepwise
conditional binary regression analysis and the resulted
odds ratios with 95 % confidence intervals were reported.
The level for significance was taken as p ≤ 0.05. Excel 2010
and SPSS 20.0 were used for statistical analysis.
Results
Patient demographics
In this series of 429 women, the mean ± SD (range)
age, weight and BMI were 59.5 ± 8.3 (50 to 83) years,
75.8 ± 13.3 (35 to 165) kgs and 29.9 ± 5.2 (14.6 to
50.8) kg/m2, respectively (Table 1). Prevalence of
obesity (BMI > 30) was 45.6 % in our population. Ac-
cording to the WHO classification, 90 had osteopor-
osis (21.0 %) and 252 had osteopenia (58.7 %). None
of the women were current smokers while 57 (13.3 %)
women reported a history of peripheral fracture after the
age of 50. The mean (SD) 25 (OH) D level in this series
was 14.5 ng/ml (12.4). Prevalence of hypovitaminosis D
was 78.1 % (335/429) for levels < 20 ng/ml and 90.39
(390/429) for levels < 30 ng/ml. Two hundred and
twenty four women (52.2 %) had vitamin D deficiency
(<10 ng/ml).
Vertebral visualization and fracture identification on VFA
In these 429 women, 62.7 % of vertebrae from T4–L4 and
99 % from T8–L4 were adequately visualized on VFA. The
percentage of vertebrae not visualized at T4, T5, and T6
levels was 57.1 %, 35.2 %, and 20.1 % respectively.
VFs were identified in 248 (57.8 %): 172 (40.1 %) had
grade 1 and 76 (17.7 %) had grade 2 or 3. Fractures were
most common in the mid-thoracic spine and at the
thoracolumbar junction.
Comparison between women according to their BMI
showed that obese women had a higher lumbar spine
and total hip BMD and less proportion of women with
Table 1 Demographic and clinical parameters of participants
(n = 429)
Minimum Maximum
Age (yrs) : m (SD) 59.5 (8.3) 50 83
Height (cm) : m (SD) 156.5 (6.1) 138 185
Weight (Kg) : m (SD) 75.8 (13.3) 35 165
BMI (kg/m2) : m (SD) 29.9 (5.2) 14.6 50.8
Years since menopause (yrs): m (SD) 9.7 (8.9) 1 50
Number of pregnancies: m (SD) 5.2 (2.3) 0 13
History of fractures: n (%) 57 (13.3)
Lumbar spine BMD (g/cm2): m (SD) 0.967 (0.19) 0.641 1.413
Total hip BMD (g/cm2): m (SD) 0.834 (0.43) 0.583 1.460
Lumbar spine T-score: m (SD) −1.5 (1.3) −5.2 4.00
Total hip T-score: m (SD) −1.01 (1.2) −4.7 3.02
Osteoporosis any site : n (%) 90 (21.0)
Vitamin D (ng/mL) : m(SD) 14.5 (12.4) 3 116
Vitamin D < 20 ng/mL : n(%) 335 (78.1)
Vitamin D < 10 ng/mL : n(%) 224 (52.2)
VFs grade 2/3: n (%) 76 (17.7)
BMI body mass index, BMD bone mineral density
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osteoporosis and VFs grade 2/3 than lean and over-
weight women (Table 2).
The group of women with moderate/severe VFs had a
statistically significant higher age, number of parity,
years since menopause and lower weight, height, and
lumbar spine and total hip BMD and T-scores than those
without a VFA-identified vertebral fracture (Table 3). They
also have lower levels of 25 (OH) D and higher proportion
of women with vitamin D below 20 ng/ml.
In this study, VFA-identified fractures occurred in
145 (57.1 %) women with osteopenia (44 (17.5 %) had
grade 2/3) and in 65 (71.9 %) women with osteoporosis
(23 (25.6 %) had grade 2/3) (p < 0.0001). Interestingly, a
fracture was identified on VFA in 38 (43.6 %) of women
with normal BMD (9 (10.3 %) had grade 2/3 VFs).
Among obese women (n = 210 (49.1 %)), VFs preva-
lence was higher in those with osteoporosis (23.1 %) vs.
those with osteopenia (12.0 %) and normal BMD (4.5 %)
(p < 0.0001). The prevalence of hypovitaminosis D was
also higher even though the difference was not signifi-
cant (100 %, 90.0 % and 54.5 % respectively; p = 0.34)
Risk factors
The prevalence of VFA-detected fractures globally in-
creased significantly for both grade 1 and grade 2/3 VFs
with age (p < 0.0001) and as BMD (p < 0.0001) and BMI
declined (p < 0.0001).
Stepwise regression analysis showed that presence of
osteoporosis was independently related to BMI and his-
tory of fractures (Table 4) while the presence of VFs
grade 2/3 was independently related to age, hypovitami-
nosis D and years of menopause (Table 5).
Discussion
This study is a large descriptive evaluation of VFA in a
population of asymptomatic postmenopausal women
and documents that VFs are significantly related to age,
hypovitaminosis D and years of menopause while the
influence of BMI was only evident on BMD.
About 18 % of asymptomatic healthy women over 50
had a previously undiagnosed grade 2/3 VFs. This preva-
lence varied according to BMI and was higher in lean
and overweight groups (22 and 21 % respectively com-
pared to obese women (13 %). However, among obese
women this prevalence was 23 % in osteoporotic
women.
Obesity, defined by the World Health Organization
(WHO) as a body mass index (BMI) ≥30 kg/m2, has
become a widespread disease. According to WHO,
worldwide prevalence has been steadily increasing to
Table 2 Comparison between women according to BMI (N = 429)
BMI≤ 25 25 < BMI≤ 30 BMI > 30
N = 75 N = 158 N = 196
Age in years: m (SD) 59.1 (7.9) 59.1 (7.9) 58.7 (7.7) NS
Weight in Kg: m (SD) 60.0 (10.1) 70.3 (9.8) 84.9 (8.3) <0.0001
Height in m : m (SD) 1.57 (0.08) 1.57 (0.05) 1.55 (0.05) <0.0001
BMI in Kg/m2: m (SD) 22.9 (1.5) 27.5 (1.3) 34.8 (1.4) <0.0001
Years since menopause: m (SD) 10.2 (8.8) 9.4 (9.3) 9.6 (8.3) NS
Number of pregnancies: m (SD) 5.0 (2.7) 4.6 (2.5) 4.9 (2.3) NS
History of traumatic fractures 13 (17.3) 16 (10.2) 28 (14.7) NS
Low dairy products intake: n (%) 32 (45.1) 75 (47.8) 97 (51.3) NS
Low physical activity: n (%) 65 (86.6) 137 (86.7) 172 (87.7) NS
Spine BMD in g/cm2: m (SD) 0.835 (0.2) 0.951 (0.1) 1.022 (0.2) <0.0001
Spine T-score: m (SD) −2.4 (1.3) −1.4 (1.2) −0.8 (1.3) <0.0001
Total hip BMD in g/cm2: m (SD) 0.808 (0.2) 0.855 (0.5) 0.913 (0.4) 0.011
Total hip T-score: m (SD) −1.7 (1.1) −1.1 (1.0) −0.5 (1.1) <0.0001
Osteoporosis any site : n (%) 31 (41.3) 38 (24.9) 20 (10.0) <0.0001
Grade 1 VFs prevalence (%) 28 (37.3) 55 (34.8) 86 (45.3) NS
Grade 2/3 VFs prevalence (%) 17 (22.3) 33 (20.9) 26 (13.7) <0.0001
SDI: m (SD) 0.54 (2.1) 0.92 (2.4) 0.51 (1.9) NS
Vitamin D in ng/mL: m (SD) 12.9 (9.1) 14.4 (11.6) 15.9 (13.2) NS
Vitamin D≤ 20 ng/mL: n (%) 58 (77.3) 122 (77.8) 149 (78.4) NS
Vitamin D≤ 10 ng/mL: n (%) 42 (56.0) 80 (50.8) 99 (50.5) NS
BMI body mass index, BMD lumbar spine BMD, SDI spinal disease index
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epidemic proportions and it has more than doubled
worldwide since 1980 [22]. Obesity is associated with
high BMD [23], while weight loss is associated with bone
loss [24]. The mechanisms responsible for this fat-bone
relationship are not fully clarified, but weight change
may act on the skeleton through changes in mechanical
loading and changes in hormone regulation on bone me-
tabolism. Several studies described the association of fat
mass with the secretion of bone active hormones from
the pancreatic beta cell (including insulin, amylin, and
preptin) and from the adipocyte (e.g., estrogens and
leptin) [25–27]. These factors alone probably do not
fully explain the observed clinical associations, and study
of the actions on bone of novel hormones related to nu-
trition is an important area of further research. Weight
changes are also related to changes in lifestyle such as
physical activity and intake of nutrients [28].
It is still not clear whether obesity-related higher BMD
increases bone strength and thereby protects against
fractures and osteoporosis. The effect of obesity on frac-
tures prevalence may vary by fracture type. Two studies
demonstrated increased risk of lower limb fractures
among obese women, but no increased risk with frac-
tures of other types [5, 29]. According to a large Spanish
study, obesity increased the risk of proximal humerus
fractures, whereas hip and pelvic fractures were found to
be less prevalent [30]. These differences may not be re-
lated to BMD but to weight determined higher impact
of falls on the peripheral skeleton, whereas other skeletal
regions are protected by subcutaneous fat deposits.
Some studies support this site-dependent fracture risk
both in obese pre- and postmenopausal women and
men [31, 32]. Concerning VFs, Laslett LL et al. showed a
Table 4 Regression logistic analysis with the presence of
osteoporosis as the dependent variable
OR total population p
Age in years 0.976 (0.927–1.077) 0.351
BMI in Kg/m2 0.847 (0.794–0.903) <0.0001
History of fractures 2.188 (1.072–4.465) 0.031
Vitamin D≤ 20 ng/mL 1.485 (0.767–2.877) 0.241
Number of pregnancies 1.051 (0.953–1.158) 0.319
BMI body mass index
Table 5 Regression logistic analysis with the presence of grade
2/3 VFs as the dependent variable
OR total population p
Age in years 1.204 (1.103–1.315) <0.0001
Vitamin D≤ 20 ng/ml 6.688 (2.244–19.937) <0.0001
Menopause duration in years 1.053 (1.009–1.098) 0.017
BMI in Kg/m2 0.975 (0.914–1.039) 0.435
Lumbar spine T-score 1.085 (0.831–1.415) 0.549
Total hip T-score 0.868 (0.642–1.174) 0.358
BMI body mass index
Table 3 Comparison between women with and without vertebral fractures (N = 429)
Absence of VFs VFs grade 1 VFs grade 2/3
N = 181 N = 171 N = 76
Age in years: m (SD) 56.1 (7.9) 60.1 (7.9) 64.7 (7.7) <0.0001
Weight in Kg: m (SD) 76.0 (10.1) 75.3 (9.8) 70.9 (8.3) <0.0001
Height in m: m (SD) 1.57 (0.08) 1.55 (0.05) 1.56 (0.05) <0.0001
BMI in Kg/m2: m (SD) 30.0 (1.5) 30.2 (1.3) 28.8 (1.4) <0.0001
Low dairy products intake: n (%) 99 (54.6) 72 (42.1) 39 (51.3) NS
Low physical activity: n (%) 165 (91.1) 148 (86.5) 72 (91.1) NS
History of traumatic fractures: n (%) 22 (12.2) 22 (12.9) 13 (17.1) NS
Years since menopause: m (SD) 6.8 (8.8) 10.4 (9.3) 16.6 (8.3) <0.0001
Number of pregnancies: m (SD) 4.5 (2.7) 4.8 (2.5) 5.5 (2.3) 0.015
Spine BMD in g/cm2: m (SD) 0.987 (0.2) 0.923 (0.1) 0.846 (0.2) 0.025
Spine T-score: m (SD) −1.1 (1.3) −1.3 (1.2) −1.5 (1.3) 0.049
Total hip BMD in g/cm2: m (SD) 0.921 (0.2) 0.850 (0.5) 0.801 (0.4) 0.011
Total hip T-score: m (SD) −0.7 (1.1) −1.0 (1.0) −1.2 (1.1) 0.004
Osteoporosis any site : n (%) 25 (13.8) 42 (24.4) 23 (30.3) <0.0001
Vitamin D in ng/mL : m (SD) 16.2 (9.1) 14.2 (11.6) 11.5 (13.2) 0.02
Vitamin D≤ 20 ng/mL: n (%) 133 (73.5) 130 (75.6) 72 (94.7) 0.001
Vitamin D≤ 10 ng/mL: n (%) 12 (34.3) 59 (57.3) 29 (65.9) 0.006
BMI body mass index, BMD lumbar spine BMD
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dose–response relationship between both prevalence
and number of vertebral deformities and multiple mea-
sures of body fat in women [33]. Ferrar et al. suggested
that some types of mild deformities may be “non-frac-
ture variants” rather than vertebral deformities. These
include short vertebral height, which they report as be-
ing more common in older, heavier women, unrelated to
osteoporosis equally prevalent in pre and postmeno-
pausal women and therefore unimportant [34]. The as-
sessment of prevalent mild VFs is still problematic, as
such deformities may reflect old trauma or are some-
times considered as an expected effect of aging [35]. Ac-
tually this point is raised when such deformities are used
to discriminate patients with or without osteoporosis
[36]. However, mild VFs (grade 1) have been shown to
be a risk factor for subsequent vertebral and non-
vertebral fracture in postmenopausal women with osteo-
porosis [37].
Vitamin D insufficiency may lead to secondary hyper-
parathyroidism resulting in greater bone turnover, bone
loss, and increased risk of fractures. This insufficiency
may result from decreased cutaneous synthesis, de-
creased dietary intake, impaired hepatic and/or renal ac-
tivation, or resistance to vitamin D action [38]. Serum
25-hydroxyvitamin D (25 (OH) D) level is considered to
be the best indicator of vitamin D nutritional status and it
has been suggested that serum 25 (OH) D values <10 ng/
ml indicate vitamin D deficiency and <20 ng/ml indicate
vitamin D insufficiency [39]. Although this was not
the case in our study, recent evidence indicates that
obesity is linked to lower serum levels of 25 (OH) D
[14, 40, 41], which may be due to poor exposure to
sunlight and/or decreased vitamin D bioavailability
(due to the sequestering effect of high quantity of
subcutaneous fat on circulating vitamin D).
Our study has strengths and limitations. The assess-
ment of fracture was carefully conducted using standard
procedures of acquisition, and standard reading of all
VFAs. All the morphometric assessments were made by
an experienced investigator. Before diagnosis of fracture,
a non-osteoporotic origin was considered for each de-
formity. The main limitation lies in the procedures used
to select subjects, who were all volunteers and ambula-
tory, and presumably not representative of the general
population. However, the population of Rabat is a mix-
ture of the Moroccan population and we believe that
there is a little impact on the prevalence of obesity,
osteoporosis or VFs or hypovitaminosis D.
Conclusion
In a large sample of Moroccan postmenopausal ambula-
tory women aged 50 years and over, we found that 18 %
of asymptomatic women show evidence of moderate/
severe VFs and that these VFs were significantly
related to age and hypovitaminosis D. We also found
that obese women had a higher BMD and lower
prevalence of VFs. However, the prevalence of VFs in
obese women was similar to non obese women in
those with osteoporosis.
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